{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:49:15Z","timestamp":1791614955913,"version":"4.3.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>\n                    This review summarizes studies evaluating the performance of the QuantiFERON-TB Gold Plus (QFT-Plus) interferon-gamma release assay (IGRA) test for\n                    <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">Mtb<\/jats:italic>\n                    ) infection in children. Literature searching was conducted using PubMed, MEDLINE and Embase (January 2017 to December 2021) and the terms \u201cchildren\u201d or \u201cpediatric\u201d and \u201cIGRAs\u201d or \u201cQuantiFERON-TB Gold Plus.\u201d Selected studies (N = 14; 4646 subjects) enrolled children with\n                    <jats:italic toggle=\"yes\">Mtb<\/jats:italic>\n                    infection, tuberculosis (TB) disease or healthy children with household TB contacts. Agreement between QFT-Plus and tuberculin skin test (TST) (kappa values) ranged from \u20130.201 (no agreement) to 0.83 (almost perfect agreement). Assay sensitivity of QFT-Plus (against reference standard of microbiologically confirmed TB disease) was 54.5%\u201387.3%, with no reported difference in children less than 5 versus greater than or equal to 5 years of age. In individuals less than or equal to 18 years of age, the rate of indeterminate results was 0%\u201333.3% (2.6% in children &lt;2 years). IGRAs may overcome the limitations of TST in young, Bacillus Calmette\u2013Gu\u00e9rin-vaccinated children.\n                  <\/jats:p>","DOI":"10.1097\/inf.0000000000003877","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T13:14:36Z","timestamp":1676553276000},"page":"e158-e165","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["QuantiFERON-TB Gold Plus Performance in Children: A Narrative Review"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-2639","authenticated-orcid":false,"given":"Danilo","family":"Buonsenso","sequence":"first","affiliation":[{"name":"Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"},{"name":"Global Health Research Institute, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Seddon","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Imperial College London, London, United Kingdom"},{"name":"Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[{"name":"Pietro Barilla Children\u2019s Hospital, Pediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Barcellini","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Children Hospital V. Buzzi, University of Milan, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling.","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(08)70182-8","article-title":"Paediatric tuberculosis.","volume":"8","author":"Newton","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"e0213304","DOI":"10.1371\/journal.pone.0213304","article-title":"Sensitivity and characteristics associated with positive QuantiFERON-TB Gold-Plus assay in children with confirmed tuberculosis.","volume":"14","author":"Nguyen","year":"2019","journal-title":"PLoS One"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(21)00145-6","article-title":"Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.","volume":"22","author":"Ho","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children.","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"e0169539","DOI":"10.1371\/journal.pone.0169539","article-title":"Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting.","volume":"12","author":"Sharma","year":"2017","journal-title":"PLoS One"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(20)30166-5","article-title":"The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.","volume":"395","author":"Martinez","year":"2020","journal-title":"Lancet"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/1040841X.2016.1262813","article-title":"Diagnosis and treatment of paediatric tuberculosis: an insight review.","volume":"43","author":"Mandal","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis.","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J Infect"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201107-1355OC","article-title":"CD8+ T cells provide an immunologic signature of tuberculosis in young children.","volume":"185","author":"Lancioni","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/ppul.25173","article-title":"Usefulness of screening tests for diagnosis of latent tuberculosis infection in children.","volume":"56","author":"B\u00f6nc\u00fco\u011flu","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"461","DOI":"10.33073\/pjm-2021-042","article-title":"QuantiFERON-TB Gold Plus test in diagnostics of latent tuberculosis infection in children aged 1-14 in a country with a low tuberculosis incidence.","volume":"70","author":"Borkowska-Tatar","year":"2021","journal-title":"Pol J Microbiol"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12887-021-02524-3","article-title":"Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN-\u03b3 release assay and IFN-\u03b3-induced protein-10.","volume":"21","author":"Ghanaie","year":"2021","journal-title":"BMC Pediatr"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"7159485","DOI":"10.1155\/2020\/7159485","article-title":"Comparison between the interferon \u03b3 release assay-QuantiFERON Gold Plus (QFT-Plus)-and tuberculin skin test (TST) in the detection of tuberculosis infection in immunocompromised children.","volume":"2020","author":"Primaturia","year":"2020","journal-title":"Pulm Med"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4269\/ajtmh.18-0674","article-title":"Evaluation of the QuantiFERON-Tuberculosis Gold Plus assay in children with tuberculosis disease or following household exposure to tuberculosis.","volume":"100","author":"Kay","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/ijmy.ijmy_44_21","article-title":"Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and QuantiFERON Tuberculosis Gold Plus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting.","volume":"10","author":"Benachinmardi","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"e00272","DOI":"10.1128\/JCM.00272-20","article-title":"Accuracy of QuantiFERON-TB Gold Plus test for diagnosis of Mycobacterium tuberculosis infection in children.","volume":"58","author":"Buonsenso","year":"2020","journal-title":"J Clin Microbiol"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jpeds.2020.02.025","article-title":"Diagnostic accuracy of QuantiFERON-TB Gold Plus assays in children and adolescents with tuberculosis disease.","volume":"223","author":"Soler-Garcia","year":"2020","journal-title":"J Pediatr"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1097\/INF.0000000000003173","article-title":"QuantiFERON-TB Gold Plus assay specificity in children and adolescents with suspected tuberculosis-a multicenter cross-sectional study in Spain.","volume":"40","author":"Soler-Garcia","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s12879-020-05465-x","article-title":"Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus.","volume":"20","author":"Corbett","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/INF.0000000000002711","article-title":"Interferon-gamma release assay testing in children younger than 2 years in a US-based health system.","volume":"39","author":"Gaensbauer","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"R28-20250614","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1093\/infdis\/jis008","article-title":"Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.","volume":"205","author":"Graham","year":"2012","journal-title":"J Infect Dis"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/thoraxjnl-2021-217592","article-title":"Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study.","volume":"77","author":"Soler-Garcia","year":"2022","journal-title":"Thorax"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination.","volume":"34","author":"Dye","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pedneo.2013.01.019","article-title":"Childhood tuberculosis: epidemiology, diagnosis, treatment, and vaccination.","volume":"54","author":"Tsai","year":"2013","journal-title":"Pediatr Neonatol"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"e20191930","DOI":"10.1542\/peds.2019-1930","article-title":"Interferon-\u03b3 release assays in children <15 years of age.","volume":"145","author":"Ahmed","year":"2020","journal-title":"Pediatrics"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"e2624","DOI":"10.1371\/journal.pone.0002624","article-title":"A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children.","volume":"3","author":"Connell","year":"2008","journal-title":"PLoS One"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/INF.0b013e3181a16394","article-title":"The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status.","volume":"28","author":"Haustein","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fped.2019.00208","article-title":"Risk factors for indeterminate interferon-gamma release assay for the diagnosis of tuberculosis in children-a systematic review and meta-analysis.","volume":"7","author":"Meier","year":"2019","journal-title":"Front Pediatr"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/INF.0b013e318214b915","article-title":"The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.","volume":"30","author":"Machingaidze","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"e0138952e0138952","DOI":"10.1371\/journal.pone.0138952","article-title":"Accuracy of QuantiFERON-TB Gold test for tuberculosis diagnosis in children.","volume":"10","author":"Sali","year":"2015","journal-title":"PLoS One"},{"key":"R40-20250614","article-title":"Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study [published online ahead of print October 25, 2022].","author":"Buonsenso","year":"1136","journal-title":"Thorax"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/cid\/ciz1138","article-title":"Tuberculosis disease in children and adolescents on therapy with antitumor necrosis factor-\u0251 agents: a collaborative, multicenter paediatric tuberculosis network European trials group (ptbnet) study.","volume":"71","author":"Noguera-Julian","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/INF.0000000000001138","article-title":"QuantiFERON TB test in children with miliary tuberculosis.","volume":"35","author":"Silvestro","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"e20173918","DOI":"10.1542\/peds.2017-3918","article-title":"Interferon-\u03b3 release assay performance for tuberculosis in childhood.","volume":"141","author":"Kay","year":"2018","journal-title":"Pediatrics"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"159","DOI":"10.12688\/wellcomeopenres.15963.1","article-title":"Concurrent adult pulmonary tuberculosis prevalence survey using digital radiography and Xpert MTB\/RIF Ultra and child interferon-gamma release assay Mycobacterium tuberculosis infection survey in Karachi, Pakistan: a study protocol.","volume":"5","author":"Khan","year":"2020","journal-title":"Wellcome Open Res"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"e034308","DOI":"10.1136\/bmjopen-2019-034308","article-title":"Infant TB infection prevention study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children.","volume":"10","author":"LaCourse","year":"2020","journal-title":"BMJ Open"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T20:09:19Z","timestamp":1749931759000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003877","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}